IsoRay, Inc.
(NYSE Amex Equities : ISR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.15%178.101.3%$463.42m
CELGCelgene Corporation
0.89%97.371.3%$421.85m
GILDGilead Sciences, Inc.
1.18%67.140.9%$393.07m
BIIBBiogen Inc.
1.90%231.991.3%$354.12m
ILMNIllumina, Inc.
0.85%346.913.5%$270.21m
REGNRegeneron Pharmaceuticals, Inc.
1.39%309.482.6%$232.17m
AAgilent Technologies, Inc.
0.20%70.111.6%$212.50m
VRTXVertex Pharmaceuticals Incorporated
1.52%172.811.9%$197.14m
ARRYArray BioPharma Inc.
56.15%46.218.2%$185.13m
EXASExact Sciences Corporation
0.60%110.4425.3%$183.98m
ALXNAlexion Pharmaceuticals, Inc.
2.50%120.882.0%$176.47m
BMRNBioMarin Pharmaceutical Inc.
4.12%84.174.3%$136.20m
MRTXMirati Therapeutics Inc.
6.48%100.372.5%$113.95m
IONSIonis Pharmaceuticals, Inc.
3.38%64.198.2%$96.24m
INCYIncyte Corporation
5.10%81.672.5%$91.75m

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.